Linking microdosimetric measurements to biological effectiveness: a
  review of theoretical aspects of MKM and other models by Bellinzona, V. E. et al.
Linking microdosimetric measurements to biological effectiveness: a
review of theoretical aspects of MKM and other models
V.E. Bellinzona 1,4, A. Attili 2, F. Cordoni 3,4, M. Missiaggia 1,4,
F. Tommasino1,4, E. Scifoni 4, C. La Tessa 1,4
Abstract
Different qualities of radiation are known to cause different biological effects at the same ab-
sorbed dose. Enhancements of the biological effectiveness are a direct consequence of the energy
deposition clustering at the scales of DNA molecule and cell nucleus whilst absorbed dose is a
macroscopic averaged quantity which does not take into account heterogeneities at the nanometer
and micrometer scales. Microdosimetry aims to measure radiation quality at cellular or sub-cellular
levels trying to increase the understanding of radiation damage mechanisms and effects. Existing
microdosimeters rely on the well-established gas-based detectors or the more recent solid-state de-
vices. They provide specific energy ε spectra and other derived quantities as lineal energy (y)
spectra assessed at the micrometer level. The interpretation of the experimental data in the frame-
work of different models has raised interest and various investigations have been performed to link
in-vitro and in-vivo radiobiological outcomes with the observed microdosimetric data. A review of
the major models based on experimental microdosimetry, with an emphasis on the Microdosimetric
Kinetic Model (MKM) will be presented in this work, enlightening the advantages of each one in
terms of accuracy, initial assumptions and agreement with experimental data. The MKM has been
used to predict different kinds of radiobiological quantities such as the Relative Biological Effects
for cell inactivation or the Oxygen Enhancement Ratio (OER). Recent developments of the MKM
will be also presented, including new non-Poissonian correction approaches for high linear energy
transfer (LET) radiation, the inclusion of partial repair effects for fractionation studies and the
extension of the model to account for non-targeted effects. We will also explore developments for
improving the models by including track structure and the spatial damage correlation information
by using the full fluence spectrum and, briefly, nanodosimetric quantities to better account for the
energy-deposition fluctuations at the intra- and inter-cellular level.
Keywords or phrases: Microdosimetry, MKM, Microdosimetric Kinetic Model, RBE, OER,
biophysical modeling, particle beam radiation.
1 Introduction
Particle therapy is becoming a well established clinical option for tumour treatment, particularly
advantageous for the highly localized dose deposition and for the radiobiological properties [Durante
et al., 2017, McNair, 1981].
While the first feature is obvious, for the macroscopic energy deposition profile, characterized by the
Bragg peak in depth, and also often by a sharper lateral penumbra, due to the small multiple Coulomb
scattering of fast and heavy particles, the second one is related to microscopic features of the peculiar
ionization pattern induced by particle radiation, for different charge and energy, down to the molecular
scale of the biological target (DNA)
The accurate prediction of relative biological effectiveness (RBE) in different positions of an irradi-
ating field is a fundamental requirement, in order to correctly estimate treatment responses [Durante
and Loeffler, 2010]. Moreover, particle RBE depends on several factors, of different nature, biological,
patient and treatment specific, because of the complexity of the mechanisms of action underlying
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tumour and normal tissue responses in radiation therapy. A numbers of models have been presented,
historically, to predict RBE, attempting to account for such effects. Among these models, four main
categories can be identified:
1. purely phenomenological models: NIRS∗ mixed beam approach [Kanai et al., 1997, Kanai et al.,
1999, Gueulette et al., 2007, Tsujii et al., 2004];
2. linear LETd-based models (developed mainly for protons) [Carabe et al., 2012, Wedenberg and
Toma-Dasu, 2014, Jones, 2015, McNamara et al., 2015];
3. Local Effect Model (LEM)-based models [Scholz et al., 1997, Scholz and Kraft, 1992, Scholz and
Kraft, 1996a, Elsa¨sser and Scholz, 2007, Elsa¨sser et al., 2008, Elsa¨sser et al., 2010, Friedrich
et al., 2012a];
4. models based on microdosimetry concepts:
(a) models based on the Microdosimetric Kinetic Model (MKM), proposed initially by Hawk-
ings in 1994 [Hawkins, 1994] and then explored and extended till nowadays [Hawkins,
2003, Kase et al., 2006, Kase et al., 2007, Sato and Furusawa, 2012, Manganaro et al.,
2017];
(b) other models, such as the repair-misrepair-fixation RMF model [Carlson et al., 2008, Frese
et al., 2012, Stewart et al., 2018], and phenomenological models based on RBE-weighting
functions [Pihet et al., 1990, Menzel et al., 1990, Wambersie, 1994, Wambersie et al., 1990].
All the different models present different advantages and limitations. While RBE is not measurable
with physical methods, the 4th category allows a strong link with physics measurements through
different types of microdosimeters. The present paper is focused on reviewing the biological effect
modellization based on the microdosimetry concepts with particular emphasis to the MKM, a widely
used model to predict the cell survival and the RBE by using microdosimetric data. This topical review
is organized as follows: the fundamental microdosimetric quantities [Zaider and Rossi, 1980, Booz
et al., 1983], required for addressing the problem, are defined in Sec.2 together with a focus on
relevant experimental quantities. Then, the original formulation of MKM is presented in Sec. 3 with
its theoretical bases (Sec. 3.1) and followed by the main extensions such as non-Poission and saturation
corrections [Hawkins, 2003, Kase et al., 2006] (Sec. 3.5), the incorporation of a track model [Kase et al.,
2007], a variable β parameter deriving from the effects of the lesion yield fluctuations in the cell nucleus
and domains, [Sato and Furusawa, 2012, Manganaro et al., 2017] in Sec. 3.8, and the generalization of
the model in case of a time structured irradiation introduced in Sec. 3.7. The available experimental
in-vitro and in-vivo validation are also reported for each extensions. Fig. 1 represents a conceptual
scheme of the main MKM formulations and extensions presented in this paper. Further, an example
of treatment planning systems (TPS) implementation of the MKM [Inaniwa et al., 2010] will be given
in Sec. 3.6. Other applications of the MKM, such as the oxygen enhancement ratio (OER) modeling
[Bopp et al., 2016, Strigari et al., 2018] and the incorporation of non-targeted effects [Matsuya et al.,
2018a] will be described in Sec. 3.9. Finally, other models based on microdosimetry as well, i.e.
the distribution function by Loncol et al. [Loncol et al., 1994] and the RMF model [Carlson et al.,
2008, Frese et al., 2012], will be presented in Sec. 4.
2 Microdosimetric distributions and their moments
The main microdosimetric quantities of interest are the specific energy z and lineal energy y [Rossi
and Zaider, 1991, Zaider et al., 1996, Booz et al., 1983, Lindborg and Waker, 2017]. The specific
energy z is the ratio between energy imparted by ionizing radiation ε and the mass m of the matter
that has received the radiation, that is
z =
ε
m
. (1)
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Figure 1: Conceptual map of the evolution of some of the microdosimetric kinetic models (blue)
considered in this review. Some of these models are currently used for RBE and RBE-weighted dose
evaluations in TPS applications (dark cyan). Solid lines refer to the consequentially of the corrections
and extensions while the dotted lines mark the theoretical bases of the considered formulation (light
gray color).
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The energy imparted by ionizing radiation ε can be represented by a sum of a finite number of energy
depositions events. The lineal energy y is the ratio between energy imparted to the matter in a volume
of interest by a single energy-deposition event, ε1, and the mean chord length in that volume, l¯, that
is
y =
ε1
l¯
. (2)
The stochastic nature of εi, implies that also z and y are stochastic quantities. In the following,
given a probability distribution f(z), we will assume that the probability that a specific energy z is
produced in the interval [za, zb] is given by ∫ zb
za
f(z)dz . (3)
When dealing with specific energy spectra, it is important to distinguish between the single-event
distribution and the multi-event distribution. It is worth stressing that, although experimental micro-
dosimetry determines single event quantities such as the ε1 or the lineal energy y, the starting point
for models are multi-event quantities such as the specific energy z and its distribution.
The single–event distribution, denoted by f1(z), is the probability distribution of z conditioned to
the fact that precisely a single-event happened. The single–event distribution is the building block to
define the more-general n−event distribution fn(z) and the multi–event distribution f(z).
The n−event distribution fn(z), that is the probability distribution conditioned to the fact that pre-
cisely n events occurred, can be computed as the n−fold convolution of the single-event distribution
f1(d), as follows
f2(z) :=
∫ ∞
0
f1(z¯)f1(z − z¯)dz¯ ,
. . . ,
fn(z) :=
∫ ∞
0
f1(z¯)fn−1(z − z¯)dz¯ ,
(4)
see [Zaider et al., 1996] for details.
Using the n−event distributions defined above, we can define the general multi–event distribution as
f(z;λn) :=
∞∑
n=0
p(n;λn)fn(z) , (5)
with p(n;λn) an integer valued probability distribution with average λn, meaning that
λn :=
∞∑
n=0
np(n;λn) .
The multi–event distribution f(z;λn) plays a crucial role in the development on microdosimetric-
based radiobiological models. It is worth noticing that f(z;λn) depends on the number of events n
only through p(n;λn), which is independent of specific energy z. Also, given p(n;λn), the single–event
distribution f1 completely determines the multi-event distribution f(z;λn).
Typically, since events are statistically independent, p(n;λn) is assumed to be a Poisson distribution
with mean value λn, so that equation (5) becomes
f(z;λn) :=
∞∑
n=0
e−λn
λnn
n!
fn(z) . (6)
Denoting by 〈z〉 the first moment of the distribution f(z;λn), formally
〈z〉 :=
∫ ∞
0
zf(z;λn)dz , (7)
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it follows that the following relation holds true,
〈z〉 = λnzF , (8)
being zF the frequency average of the single-event specific energy defined as
zF :=
∫ ∞
0
zf1(z)dz , (9)
see, [Zaider et al., 1996, Chapter II]. In microdosimetry, z¯ is often identified with the absorbed dose
D; we shall use this identification in the following of the paper.
Above argument, with particular reference to equation (8), yields the form for the average value λn
of the multi–event distribution to be
λn =
D
zF
, (10)
see, [Zaider et al., 1996, Booz et al., 1983]. Again, in the following, if not differently specified, we will
consider λn to be defined as in equation (10).
Further computations, see, [Zaider et al., 1996, Booz et al., 1983], shows that regarding the second
moment it holds ∫ ∞
0
z2f(z;λn)dz = D
2 + zDD , (11)
with zD the dose average of the single-event specific energy
zD :=
1
zF
∫ ∞
0
z2f1(z)dz =
∫∞
0 z
2f1(z)dz∫∞
0 zf1(z)dz
. (12)
Notation and computations performed in the current section will be extensively used thorough the
work to formally derive analytical solution for some relevant biological endpoints, typically the cell–
survival probability, starting from a mathematical model for DNA damage.
In the following, we assume that a cell nucleus is divided into Nd domains, so that above microdosi-
metric distributions will be used both on single domain and on the whole cell nucleus. In particular,
the superscript (c, d) will denote that the corresponding quantity, such as as a microdosimetric dis-
tribution or a corresponding average value, is considered on the domain d of the cell c. Further, the
subscript n denotes that microdosimetric distributions are on the cell-nucleus whereas if no subindex
is specified it is assumed that the corresponding distribution is on the domain.
In the following treatment, in order to make computations less heavy as possible, whenever we will
say that we average a function g(z) over all domains of a cell nucleus, denoted for short by 〈g〉(c)d , it
formally means
〈g〉(c)d :=
1
Nd
Nd∑
d=1
∫ ∞
0
g(z)f (c,d)(z; zn) dz . (13)
where f (c,d)(z; zn) denotes the probability density of z in a domain for cell with nucleus specific energy
zn.
Similarly, by averaging over all cell population a function gn(z) defined over a nucleus, denoted by
〈gn〉c, we mean
〈gn〉c := 1
Nc
Nc∑
c=1
∫ ∞
0
gn(z)f
(c)
n (z;D)) dz . (14)
where Nc is the total number of the considered cells and f
(c)(z;D) denotes the probability density of
z in a nucleus for a population of cells irradiated with macroscopic dose D. Notice that in practical
computations of an irradiated population of cells, such as those described in the immediate next
sections, the probability densities are reasonably considered equals among different cells and domains.
In this case we will drop the indexes c and d and the sums in equations 13 and 14 can be carried out
implicitly:
〈g〉d =
∫ ∞
0
g(z)f(z; zn) dz (15)
〈gn〉c =
∫ ∞
0
gn(z)fn(z;D)) dz . (16)
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2.1 Experimental quantities
In order to account for the different densities and sizes of the sites of radiobiological interests (e.g.
the cell nucleus and the domain), the specific energy z used in the models as described in the following
sections can be obtained experimentally through the lineal energy y defined in equation (2).
The lineal energy can be measured through a microdosimeter detector, where the most frequently
used are the tissue-equivalent proportional counters (TEPC) [Conte et al., 2013, Lindborg et al.,
1999, Wilson and Field, 1970, Nikjoo et al., 2002]; analogous information can be achieved also by solid-
state detectors and gas electron multiplier (GEM) detectors [Byun et al., 2009, Orchard et al., 2011],
recently investigated for their use in microdosimetric measurements [Braby, 2015, Schuhmacher and
Dangendorf, 2002]. The relationship between l¯ of the tissue-equivalent volume of the microdosimeter,
from which the lineal energy is calculated, is given approximately by
l¯ = l¯det
ρdet
ρ
(17)
where l¯det is physical mean cord of the detector and ρ, ρdet are the densities of the tissue and the de-
tector material respectively. For more general conversion methods of microdosimetric spectra between
different materials and shapes see for example [Magrin, 2018].
The theoretical single-particle imparted energy, z1, can be estimated from the lineal energy y as:
z1 = yl¯t/mt (18)
where l¯t, mt are the mean chord length and the mass of the biological site of interest respectively. The
mean dose-averaged specific energy zD can be obtained from the mean-dose lineal energy yD as:
zD =
l¯t
mtyF
∫ ∞
0
y2f(y) dy =
l¯t
mt
yD (19)
where yF is the frequency-mean lineal energy.
In the case of a spherical volume ρt = 1 g/cm
3, the specific energy z1 is linked to the lineal energy y
[Kase, 2012] as
z1 (Gy) = 0.204× y (keV/µm)
[2rdet (µm)]2
(20)
the constant factor is due to the Gy-keV conversion (1 Gy= 1.6×10−16keV) and the consideration
that the mean chord length in the case of a sphere is l¯ = 4/3rdet
3 Microdosimetric Kinetic Model
The Microdosimetric Kinetic (KM) model has been developed by Roland B. Hawkins [Hawkins,
1994] by taking inspiration from the theory of dual radiation action (TDRA) [Kellerer and Rossi,
1972, Kellerer and Rossi, 1978], the repair-misrepair model [Tobias, 1980, Tobias, 1985] and the
lethal-potentially lethal (LPL) model [Curtis, 1986, Curtis, 1988]. In the following sections, after a
brief description of the historical bases of the model and the details of its original formulation, we
compare and contrast the more recent developments of the model.
3.1 Historical bases
This section presents a brief explanation of the theoretical formulations on which the considered
models are based on.
The theory of dual radiation action (TDRA) [Kellerer and Rossi, 1972, Kellerer and Rossi, 1978]
assumes that, after the cell irradiation, the number of lethal lesions in a small volume of the cell
nucleus, defined site, is proportional to the square of the specific energy z deposited in that site:
ε(z) = Kz2 (21)
where the K factor expresses the rate of combination of sub-lesions and formation of lesions. In the
development of the MKM [Hawkins, 1994] this postulate is generalized, adding the quadratic propor-
tionality to the lethal damages and therefore assuming a linear-quadratic dependence on z.
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MKM inherits the concept of damage time evolution for the repair or conversion into a lethal unrepara-
ble lesion (chromosome aberration) [Van Houten et al., 2018, Schu¨rmann et al., 2018] of the primary
potentially lethal radiation induced lesions in DNA from the repair-misrepair (RMR) model, developed
by Tobias et al. to interpret radiobiological experiments with heavy ions [Tobias, 1980, Tobias, 1985].
The RMR model considers that the amount of DSBs in the DNA, U(t), is linearly proportional to the
radiation dose rate; a number of DSBs evolve in lethal lesions, L(t), while most breaks are successfully
repaired with a first-order process. The model includes also the possibility of a misrepair as a second-
order process since it involves two broken DNA strands to form a chromosomal aberration. The idea
of misrepair was initially applied by Lea and Catcheside [Lea and Catcheside, 1942] to describe the
formation of chromosome aberrations in tradescantia.
These assumptions yield the following kinetic equations:
dU
dt
= δD˙︸︷︷︸
damage
− λU︸︷︷︸
repair
− κU2︸︷︷︸
misrepair
dL
dt
= (1− φ)λU︸ ︷︷ ︸
unsuccessful repair
+ σκU2︸ ︷︷ ︸
lethal misrepair
(22)
where δ is the number of DSBs induced per Gy of radiation, λ is the rate at which DSBs are repaired
κ is the rate constant for second-order DSB interaction and φ is the fraction of simple repairs that are
successful. The fraction of misrepairs that result in a lethal lesion is σ.
Like the RMR model, the lethal-potentially lethal (LPL) model [Curtis, 1986, Curtis, 1988] accounts
that the damage caused by ionizing radiation at the molecular level to cell death can be separated into
two broad classes: that which has the potential of being lethal, P (t) (by fixing or binary misrepair)
but also can be repaired correctly and that which is lethal ab initio and cannot be repaired correctly,
L(t). Both lesions are linearly proportional to the radiation dose-rate [Kuang et al., 2016] and after
a prescribed time, the remaining potentially lethal lesions become lethal as described in the following
equations:
dP
dt
= δηD˙︸︷︷︸
reparable damage
− λP︸︷︷︸
repair
− κP 2︸︷︷︸
misrepair
dL
dt
= δ(1− η)D˙︸ ︷︷ ︸
irreparable damage
+ κP 2︸︷︷︸
lethal misrepair
(23)
where η is the amount of radiation induced DSBs that are repairable, while all the other parameters
corresponds in meaning to the ones in Eq. 22.
The solution of the model equations are similar in form to those for the RMR model and the LPL.
However, in contrast to the RMR, the LPL predicts that the probability of the interaction between
potentially lethal lesions is strongly dependent to the dose rate and becomes negligible for low dose
rates, where only the channel of the direct creation of lethal events through λ dominate.
3.2 Original formulation and general considerations
The MK model computes the cell survival in a way that emphasizes subcellular microdosimetry
while abstracting the specific description and modeling of the radiation-induced damage to the cell by
using the general categories of lethal and potentially lethal lesions as defined in [Curtis, 1986]. More
specifically, the MK model is based on the following funding assumptions [Hawkins, 1994, Hawkins,
1996, Hawkins, 1998]:
1. the cell nucleus is the sensitive target and it is divided into Nd sub-units, called domains, similar
to the sites of TDRA. In general domains have a variety of shapes that fit together to fill the
nucleus. In the case of mammalian cells, the domain diameter is usually considered to be in the
range 0.5 ≤ dd ≤ 1.0µm and the number of domains per nucleus is in the order of few hundred;
2. radiation can create two different types of DNA damages, called of type I and II;
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3. type I lesions represents damage that cannot be repaired, for this reason will be also called lethal
lesion. On the contrary type II lesions, also called sublethal or potentially-lethal lesions, can
repair or convert into a lethal lesion either by spontaneous conversion or by binary combination
with another sublethal lesion;
4. type I and II lesions are confined to the domain in which they are created. This assumption
defines a sub-nuclear correlation length among lesions in a way that the interaction of two lesions
can happen only if they are in close spatial proximity. Specifically, a pair of type II lesions can
combine to form a type I lesion only if they are created in the same domain;
A remark on this assumption is needed. The idea behind the division of a cell into subvolumes
arises because couples of type II lesions are all likely to happen in a short time period, even for
lesions that are far away in the cell-nucleus. In order to overcome such a problem, a possible
approach is to divide the nucleus into smaller subdomains so that interactions might happen
solely inside a single volume, as it is assumed in the MKM. It is important to stress the key role
that the choice of such domains plays. In fact, if too big domains imply that far away lesions
can interact, on the contrary, too small domains yield that the overall number of lesions inside a
single domain is so small that couple interactions is less likely to happen. Therefore, the choice
of the best possible division of the cell nucleus into smaller domain is a key aspect of the model
and different choices of domains can in principle lead to different results. A possible solution to
reduce the sensibility of the model from the arbitrary choice of the domains, it is to assume that
interactions are possible also within different domains, allowing therefore lesions to move from
one domain to another or pairs of lesions to interact if in adjacent domains.
5. the initial number of type I and II lesions in a single domain d is proportional to the specific
energy z deposited in the domain.
If above assumptions hold then the following further assumptions are made regarding the repro-
ductive survival of the cell:
6. if at least one domain suffers a lethal lesion it is considered “dead”;
7. if at least one domain is dead, then the whole cell is “dead”.
It has to be noted that, while the MK assumptions reported in this section are general, in many
studies [Matsuya et al., 2014, Chen et al., 2017] the lethal lesions are intended to represent a specific
complex DNA damage (e.g. lethal chromosome aberrations) that cannot be repaired, whereas the
creation of sublethal lesions are explicitly associated to the induction of double-strand breaks (DSB)
that can be repaired.
Following the MK notation, we denote by x
(c,d,z)
I (t) and x
(c,d,z)
I (t) the time-dependent average number
of type I and type II lesions for a cell-domain (c, d) caused by an acute dose z(c,d) at t = 0 deposited
in the cell c and domain d. Starting from the concept, introduced in the TDRA, that a cell experi-
ments a randomly varying dose in a microscopic volume [Booz et al., 1983, Rossi and Zaider, 1991],
the microscopic specific energy z(c,d) is considered as a random variable with 〈〈z(c,d)〉d〉c = D, the
macroscopic dose experienced by the cell population.
Type II lesions are assumed that can be repaired with a constant repairing rate r or can be converted
to irreparable lesions through a first order process with constant rate a, or at the second order, repre-
senting pairwise combinations, with constant rate b. The average number of type I and II lesions at
time 0 is proportional to the amount of specific energy z(c,d) with factors λ and κ. These assumptions
formally define the following set of coupled ODE similar in concept to equations (22) x˙
(c,d,z)
I = ax
(c,d,z)
II + b
(
x
(c,d,z)
II
)2
,
x˙
(c,d,z)
II = −(a+ r)x(c,d,z)II − 2b
(
x
(c,d,z)
II
)2
,
(24)
subject to the initial average number of lesions
x
(c,d,z)
I (0) = λz
(c,d) , x
(c,d,z)
II (0) = κz
(c,d) . (25)
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In the case of ion radiation, typically the rate of pairwise combination between type II lesions is
negligible with respect to the first order evaluation of xII for low does [Hawkins, 1996], that is,
2b
(
x
(c,d,z)
II
)2  (a+ r)x(c,d,z)II (26)
so that the time-evolution of the average number of type II lesion can be rewritten as
x˙
(c,d,z)
II = −(a+ r)x(c,d,z)II . (27)
The solution to equation (27) can be seen to be
x
(c,d,z)
II (t) = κz
(c,d)e−(a+r)t . (28)
Substituting equation (28) into the kinetic equations (24) and integrating x
(c,d,z)
II with respect to time,
it follows that
x
(c,d,z)
I (t) = λz
(c,d) + aκz(c,d)
(
1− e−(a+r)t
a+ r
)
+ bκ2
(
z(c,d)
)2(1− e−2(a+r)t
a+ r
)
. (29)
An example of the temporal evolution of lesions in a cell is depicted in Fig. 2.
Figure 2: Time evolution of xI and xII damages for a single instantaneous irradiation as described by
Eq. 29 and Eq. 28 respectively (a). Generalization of the temporal evolution for any time structured
irradiation as describe in Sec. 3.7 and 3.8.1. The dotted vertical lines represent the energy deposition
events in the cell nucleus due to the passage of ionizing particles (b). Figure from [Manganaro, 2018]
It is important to remark that the exponential decay in Eq. 29 derives from the assumption of
first order repair kinetics and that it could likely represents an approximation of more complex repair
kinetics present in the real cell [Dikomey and Franzke, 1986, Fowler, 1999, Dale et al., 1999, Carabe-
Fernandez et al., 2011]. Postulating that the total number of lesions xI(t)+xII(t) ∼ NDSB(t) describes
specifically the number of double strand breaks (DSBs) in the DNA, the repair kinetics represented
in Eq. 29 can be verified through H2AX phosphorylation mapping experiments (γ-H2AX) [Schettino
et al., 2011, Mariotti et al., 2013]. In the case of high-LET particle irradiation, such as carbon ions,
the presence of a plateau (offset) in the observed NDSB(t) [Asaithamby et al., 2008, Carabe-Fernandez
et al., 2011, Asaithamby et al., 2011], suggests the presence of irreparable complex clustered damage
that can be related directly to the parameter λ of the kinetic equations, and hence to the linear
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parameter α0 of the macroscopic cell survival LQ formulation that will be introduced in the following
(see Eqs. 32 and 36).
In order to connect above explicit solution of Eq. 29, i.e. the average number of type I and II lesions
given a certain energy deposition z(c,d), to the survival probability one more fundamental assumption
must be made.
8. the lethal lesion distribution given a specific energy z follows a Poisson distribution.
Under the Poisson distribution assumptions stated above, the probability that the domain d survives
at time t → ∞ when exposed to the specific energy z(c,d), denoted by s(c,d)(z(c,d)), can be computed
as the probability that the random outcome of a Poisson random variable is null. Therefore s(c,d) is
given by
s(c,d)(z(c,d)) = e− limt→∞ x
(c,d,z)
I (t) . (30)
Using equation (29), it can be seen that that the average number of lethal lesion given z(c,d) as t→∞
can be computed as
lim
t→∞x
(c,d,z)
I (t) =
(
λ+
aκ
a+ r
)
z(c,d) +
bκ2
2(a+ r)
(
z(c,d)
)2
, (31)
so that the log-survival for the domain d is given by
log s(c,d)(z(c,d)) = −Az(c,d) −B
(
z(c,d)
)2
, (32)
with A and B defined as
A =
(
λ+
aκ
a+ r
)
, B =
bκ2
2(a+ r)
. (33)
We remark that these constants are independent of the domain d and specific energy z(c,d) of deposited
in the domain d.
Indicating with S
(c)
n (z
(c)
n ) the probability of the reproductive survival of the cell c that has received
exactly a specific energy z
(c)
n in the nucleus, the log-survival of this quantity, − logS(c)n (zn) = x(c)I,n(zn),
represents the total lesions in the whole cell nucleus, and can be therefore evaluated by summing of the
single–domain log–survival − log s(c,d)(z) = x(c,d)I (z) over all the domains of the cell, or, equivalently,
by formally using the average of this quantity over the domains. Assuming that the probability density
function are the same over all domain and cell, we can drop the index c and d and use equations 15
to write
logSn(zn) := −xI,n(zn)
= −Nd〈xI(z)〉d = −Nd〈log s(z)〉d
= −Nd
(
A〈z〉d +B〈z2〉d
)
= −NdA
∫ ∞
0
zf(z; zn) dz −NdB
∫ ∞
0
z2f(z; zn) dz ,
(34)
where f(z; zn) denotes the probability density of z in a domain for a cell with a mean specific energy
in the nucleus zn. In particular, as shown in Section 2, the following holds
zn = 〈z〉d =
∫ ∞
0
zf(z; zn)dz . (35)
Using equations (11) and (12) derived in Section 2, the log survival in equation (34) can be written as
logSn(zn) = −(α0 + zDβ0)zn − β0 (zn)2 , (36)
with α0 := NdA and β0 := NdB. Also, zD is the dose average z per event in a domain, obtained from
equation (12) applied to the domain.
Notice that in equation (34) we have used the notation f(z; zn) to denote the multi–event distribution,
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rather than f(z;λn) as done in Section 2. This is due to the fact that, since the following relation
holds true
λn =
zn
zF
, (37)
we have preferred to specify the dependence upon the multi–event distribution average.
In order to obtain the cell survival S(D) for a population of cells irradiated with macroscopic dose D,
the quantity Sn(zn) defined in equation 34 should be averaged accounting for the distribution of the
specific energy zn over the cell population. In terms of the logarithm of the cell population survival,
logS, under again the assumption that all the cells have the same probability distribution of specific
energy zn, this can be written as:
logS(D) := log〈Sn(zn)〉c
= log
(∫ ∞
0
Sn(zn)fn(zn;D) dzn
)
,
(38)
where similar to above we have denoted by fn(zn;D) the probability density of zn for a macroscopic
absorbed dose D over the cell population, i.e.
D = 〈zn〉c =
∫ ∞
0
znfn(zn;D)dzn . (39)
We remark that equation (38) is fundamentally different from equation (34) since the it considers
the average of the argument of the logarithm whereas in equation (34) the average of the logarithm
has been taken. This basically indicates that, due to the stochastic nature of zn, the distribution of
lethal lesions logSn(zn) over the cell population is in general non-Poisson and hence that the log of
the survival cannot be directly related to the average number of lethal lesions per cell, logS(D) 6=
−〈xI,n(zn)〉c. However, provided that the variance of zn is small, a Poission approximation is assumed
and the same procedure used to obtain equation (34) can be used. In this approximation equation
(38) can be written as follows,
logS(D) = log〈Sn(zn)〉c
≈ −〈xI,n(zn)〉c = 〈logSn(zn)〉c
=
∫ ∞
0
log (Sn(zn)) fn(zn;D) dzn
= −(α0 + (zD − zn,D)β0)D − β0D2 ,
(40)
with zn,D the dose average zn in the nucleus per event. All the quantities zn,D; zD and zn ≈ 〈zn〉c = D
are assumed to be the same for each cell or domain. All other notations are used as previously
introduced. Since the size of the domain is usually much smaller than the size of the nucleus, it holds
that zn,D  zD, (see [Hawkins, 1996]), so that we eventually obtain
logS = −αPD − βD2 , (41)
with
αP := α0 + zDβ0 , β := β0 . (42)
where the subscript P indicates that the relationships hold when the assumption of Poisson distribution
of lethal lesions among the irradiated cell population is reasonable, i.e. for low-LET irradiation, as it
is discussed in the following section.
A further refinement of the MKM kinetic equations involves a fourth type of possible interaction, that
happens at time tr. The following is assumed:
9. after a time tr > 0, all sub–lethal lesions that are not either dead or repaired, automatically
transform into lethal lesions.
The mathematical formulation of the main kinetic equations remain the same as in equations (24)–
(28)–(29) in the time interval t ∈ [0, tr). As soon as tr passes, all type II lesions that have not been
either repaired or died, the will immediately be converted into type I lesions, meaning
xII(t) = 0 , t > tr . (43)
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The solution for the average number of type I lesion can be now explicitly found for t > tr adding all
type II lesions that persisted after tr passes, that is
x
(c,d,z)
I (t) = x
(c,d,z)
I (t) + x
(c,d,z)
II (tr) , (44)
so that we obtain
lim
t→∞x
(c,d,z)
I (t) = limt→∞x
(c,d,z)
I (t) + x
(c,d,z)
II (tr) =
=
(
λ+
aκ
(a+ r)
+
κr
(a+ r)
e−(a+r)tt
)
z(c,d)+
+
bκ2
2(a+ r)
(
1− e−2(a+r)tr
)(
z(c,d)
)2
.
(45)
Proceeding as above, taking therefore the average over all cell domains and cell population, we obtain
the generalization of equation (41) to be
logS = −αD − βD2 , (46)
with 
α := α¯0 + z
(c,d)
D β¯0 , β := β¯0
α¯0 := Nd
(
λ+ aκ(a+r) +
κr
(a+r)e
−(a+r)tt
)
,
β¯0 := Nd
bκ2
2(a+r)
(
1− e−2(a+r)tr) . (47)
3.3 Link to the radiobiological observables
From equations (41) and (42) it is possible to obtain the direct link of the model to the phe-
nomenological LQ formulation of the cell survival. The α coefficient is therefore explicitly dependent
on the radiation quality through a single term, the dose average specific energy per single event zD,
that can be related to microdosimetric measurements (equation 19). It has to be noted that, in this
formulation of the MK model, there is no explicit dependence to the radiation quality in the quadratic
coefficient β0, that is considered constant, analogously to the result of the TDRA [Kellerer and Rossi,
1972]. The latter is an approximation of the model that is in contrast with experimental observations
[Prise, 1998, Anderson et al., 2010, Friedrich et al., 2012b] although in many cases, considering in
particular the experimental uncertainties associated to the β0 determination (see for example Fig. 3),
it is assumed to be reasonable. In an evolution of the model which accounts for the stochastic aspects
of the irradiation, as described in sections 3.8.2 and 3.8.1, this approximation will be relaxed and the
β coefficient will be considered dependent on the quality of the radiation.
From the knowledge of the LQ parameters is possible to derive the dose (D) and radiation quality
(zD) dependent RBE [Dale and Jones, 1999, Carabe-Fernandez et al., 2007]:
RBE(D, zD) =
1
2D
(
−1 +
√
1 +
4
R
(
RBEα(zD)D +
(RBEβD)2
R
))
(48)
where R = αX/βX , RBEα(zD) = α(zD)/αX , RBEβ =
√
β/βX , and αX and βX are the phenomeno-
logical LQ coefficient for the photon reference radiation.
Since the parameters α0 and β0 are assumed to be independent on the radiation quality, and
β = β0, it is possible to identify α0 = α(LET→ 0) and β0 ' βX (RBEβ ' 1). In the case of high-LET
evaluations, since the single-particle dose averaged specific energy zD for photons can be considered
negligibly small relative to that of high-LET radiation, α0 ' αX and hence is possible to write
RBEα =
α0
αX
+
β0
αX
× z(c,d)D ≈ 1 +
1
R
× zD (49)
where ratio R can be derived from a nonlinear regression analysis of measured cell survival data for a
low-LET reference radiation. Equation (49) can be generalized as
RBEα = k1 +
k2
R
× yD (50)
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where k1 and k2 are phenomenological parameters. Since zD is proportional to the dose-averaged
lineal energy yd (equation 18), Eq. 50 is analogous to the linear models based on the dose average
LET (LETD) used for protons [Carabe et al., 2012, Wedenberg and Toma-Dasu, 2014, Jones, 2015,
McNamara et al., 2015]. Following the MK model premises, Eq. 50 could also be generally used
for other ions to describe the linear growth of the RBE as a function of the LETD in the low-LET
region (see Fig. 3). However the linear dependence on the LET fails to be adequate in the region of
mid- and high-LET as found in experimental studies [Friedrich et al., 2012b]. In these regions further
corrections to the MK model are used to reproduce the experimental observations. Different corrective
approaches for high-LET irradiation are described in the following sections.
Figure 3: a) Experimental in vitro RBEα (panel a) and RBEβ (panel b) versus LETD/R. The data
have been taken from the Particle Irradiation Data Ensemble (PIDE v3.2) database [Friedrich et al.,
2012b]. The continuous line in (a) is the fit of the linear Poisson solution of the MK model (Eq. 50)
carried out in the low-LET region (LETD < 20 keV/µm) for ion irradiation with charge Z ≤ 11. The
dashed line in (b) corresponds to the constant RBEβ = 1
3.4 Non-Poisson correction
In the approximation introduced in equation (40) it is assumed that the variance of the specific
energy zn among cells is sufficiently small. In this assumption the number of lethal events follows the
same Poisson distribution in each cells, with average xn,I .
However, in general, the specific energy received in the cell is a stochastic quantity, that varies from cell
to cell, bringing also a deviation from the Poisson distribution when considering the whole population
of irradiated cells. We remark that this deviation is present even if the radiation is perfectly mono-
energetic. In this case the variance of the specific energy zn arises from the fluctuation of the number
of particles that are hitting the cells. The fluctuations are particularly relevant when the LET of
the particle is relatively high since, given a macroscopic dose D, the average number of high-LET
particles interacting with the cell is lower than the number of low-LET particles. To account for the
non-Poisson distribution of the lethal events a correction to the MK model has been introduced by
Hawkins in 2003 [Hawkins, 2003] bringing a deviation from the linear behaviour of the RBE vs. LET,
described in equation (49), in the high LET region.
The effect of the non-Poisson distribution of lethal lesions is considered by explicitly evaluating the
fraction of hit and non-hit cell nuclei. Considering a very low dose high-LET irradiation, D  1, the
probability for a cell to interact with more than one particle is negligible. In this case the population
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of cells can be subdivided in a fraction Φ of cells that suffer a single particle interaction and a fraction
1 − Φ of cell with zero interactions. We denote with xI,n(zn,D) the average number of type I lethal
lesions in the fraction Φ of cells whose sensitive nucleus has been hit by a single particle imparting
exactly a specific energy zn,D in the nucleusThen, recalling equations (40)– (42), we obtain
xI,n(zn,D) = − logS(zn,D) = (α0 + zDβ0)zn,D + β0z2n,D . (51)
It is possible to explicitly write the global surviving fraction of cells (including both hit and non-hit
nuclei) as:
S(D) = (1− Φ) + Φe−xI,n(zn,D) . (52)
This corresponds to consider a probability density function fn(zn;D) = (1−Φ)δ(zn) + Φδ(zn − zn,D)
in equation (38). Since the number of lethal lesions per cell averaged over the whole cell population
(including both hit and non-hit nuclei) exposed to the macroscopic dose D can be directly evaluated
as
〈xI,n(zn)〉c = ΦxI,n(zn,D) , (53)
equation 52 can be rewritten as
S(D) = 1 +
〈xI,n(zn)〉c
xI,n(zn,D)
(e−xI,n(zn,D) − 1)
= 1 +
[
e−(α0+zDβ0)zn,D−β0z
2
n,D − 1
(α0 + zDβ0)zn,D + β0z2n,D
] (
(α0 + β0zD)D + β0D
2
) (54)
Taking the log of S, expanding around D = 0 and dropping terms in D2 or higher powers, the linear
term of logS(D) can be written as
− logS(D)|D→0 ≈ (α0 + zDβ0)×
(
1− e−(α0+zDβ0)zn,D−β0zn,D
(α0 + zDβ0)zn,D + β0z2n,D
)
×D
≈ αP ×
(
1− e−αP zn,D
αP zn,D
)
×D
= αNP ×D
(55)
where αP is the Poisson α coefficient defined in equation (42), while the subscript NP denote the
Non-Poisson corrected α coefficient. Following also the original formulation of Hawkins [Hawkins,
2003], in equation (55) the quadratic term z2n,D  zn,D was also neglected.
Notice that in the above equations a subtle approximation is assumed in order to match the request
of having a Poisson distribution in the lethal events, with only a single well defined value of zn = zn,D
when the particle hits the cell. Generally, this is not the case and the specific energy can also vary
as a function of the impact parameter of the particle with respect to cell nucleus. Still, xI,n(zn,D) is
used as an estimation of the average number of lethal lesions in those cells that have suffered a single
event after exposure to a dose D. This assumption can be reasonable when low energy particles with
high LET (see also section 3.6) are considered.
The Non-Poisson correction to the RBE in the limit of zero dose (RBEα) is given by
RBEα,NP =
αNP
αX
=
(
1− e−αPzn,D
αPzn,D
)
RBEα,P (56)
with RBEα,P given by equation (49). No corrections are applied to the RBEβ that is still assumed
constant (RBEβ ∼ 1) and independent on the quality of the radiation.
The correction causes the RBEα to be less than indicated by the extrapolation of the linear
relationship (equation 50) to higher LET, and to pass through a maximum in the range of LET of 50
to 150 keV/µm. This behaviour is compatible with several experimental studies from the literature
[Friedrich et al., 2012b] and it shows also a sensitivity of the maximum of the RBE to the response
of the cell at low-LET, related to the parameter R = αX/βX [Weyrather and Debus, 2003]. An
exemplification of the RBE behaviour and the prediction of the model is reported in Fig. 4. In Fig. 5
some qualitative implications of the non-Poisson regime in high-LET ion beam therapy are depicted.
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Figure 4: Comparison of MKM estimates of particle RBEα to experimental values for V79 cells. Red
curves show RBEα for cells synchronized at G1-S transition for cross sections of σ = 32.0 and 24.6µm
2
(reference radiation: 250 kVp X-rays, αR = 0.234Gy
−1, βR = 0.042Gy−2). Black curve shows RBEα
for cells synchronized in late S phase for cross sections of σ = 18.2µm2 (reference radiation: 250 kVp
X-rays, αR = 0.064Gy
−1, βR = 0.0165Gy−2). Dashed lines represent RBEα = 0.02 + 0.19 × LET.
in the Poission regime. Experimental data are from [Bird, 1980, Bird et al., 1983], plot taken from
[Stewart et al., 2018].
3.5 The saturation correction
Kase et al. [Kase et al., 2006] introduced a correction factor in the MK model to account the
decrease in RBE due to the overkill effect observed in high-LET radiations (see for example Fig. 6).
The correction factor was applied to dose-averaged saturation-corrected specific energy per event, z∗1 ,
for mixed radiation field with wide-ranging spectra.
In terms of lineal energy, the corrected value of yD (and hence zD) was obtained by applying
a correction for each lineal energy component of the lineal energy spectrum. The correction of the
components was obtained by using an empirical saturation parameter y0 based on the saturation
correction method introduced by [Powers et al., 1968] and then used in the TDRA [Kellerer and
Rossi, 1978]
y∗D =
y20
∫ [
1− exp (−y2/y20)] f(y) dy∫
yf(y) dy
(57)
The saturation parameter indicates the lineal energy above which the correction due to the overkill
effects became important.
The correction to cell survival is then obtained by evaluating the corrected dose-averaged saturation
specific energy per event z∗D in the domain, which can obtained from the corrected dose-averaged lineal
energy (57) using the relationships reported in Eq. (12) and (19):
z∗D =
l¯d
md
y∗D =
y∗D
ρpir2d
(58)
where ρ, rd, l¯d and md are the density, radius, mean cord length, and mass of the domain, respectively.
The equation for the cell survival (equation (41)) is then modified as follows:
− ln(S) = (α0 + β0z∗D)D + β0D2 (59)
Considering the linear term in the macroscopic dose D, the corrected α∗ coefficient is hence:
α∗ = (α0 + β0z∗D) (60)
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Figure 5: Evaluation of the RBEα vs. LETD evaluated via equation (56) in combination with an
amorphous track model (see section 3.6) for proton (a) and for carbon and other ions (b). Using the
same x axis of the plot is reported for comparison the LETD volumetric distribution (filled areas)
found in a patient (a pediatric brain tumor case) irradiated with a primary beam of protons (a) and
carbon ions (b). The LETD distribution is normalized and evaluated in 3 volumes: total body (red),
brainsteam (green) and the planning target volume, PTV, (blue). Annotated in the plot are the low-
LET range for the Poisson regime, applicable mainly for the proton treatment, and the Non-Poisson
regime, in the case of high-LET carbon ion treatment (for both the primary carbon ions and the
fragments). The gray bands represent the 95% confidence band obtained with a bootstrap procedure
to the fit of the input parameters (α0, β0, Rn, rd) of the model to the in-vitro experimental data taken
for cells with R ' 10 Gy from the PIDE database [Friedrich et al., 2012b]. The evaluations have been
carried out with a research TPS [Russo et al., 2015].
No correction is considered for the β coefficient and it is still assumed to be independent on the energy
spectrum.
An example of the prediction MK model modified with the saturation correction compared with
experimental data is reported figure 6, where the α vs. yD for HSG cells irradiated with carbon ions is
shown. It is interesting to note, by comparing equations (55) and (60), that the saturation correction
can be considered an alternative way to describe the non-Poisson correction defined in section 3.4,
since both factors modulate the behaviour of RBEα in similar ways (see also figure 4). In particular
16
it was shown in [Kase et al., 2006] that in the case of monoenergetic spectra, the equations (55) and
(60) are functionally equivalent for y < 500 keV/µm. Thus, by matching these equations in the limit
of low LET (yD → 0), and defining zn,D = yD/ρpiRn, with Rn the radius of the nucleus, analogously
to equation (58) for the domain, is possible to link the saturation correction parameter y0 with the
other parameters of the model
y0 =
ρpirdR
2
n√
β0(r2d +R
2
n)
(61)
A typical used value of the saturation parameter was y0 = 150 keV/µm [Kase et al., 2006, Inaniwa
et al., 2010].
Other quantities that one needs to determine for the RBE evaluations are the lineal energy spectra,
obtainable with a microdosimeter detector such as TEPC [Lindborg and Waker, 2017], and the values
of α0, rd and RN from which the correction to the y
∗
D is calculated. The α0 and rd coefficients can
be extrapolated experimentally from the initial slope of the survival curves (equation 60) for low-LET
irradiation (in the limit of yD → 0 and D → 0)
rd =
√
β (yD − (yD)X)
ρpi (α− αX)
lim
yD→0
α ≡ α0 = αx −
(
α− αx
yD − (yD)X
)
(yD)X
(62)
where ρ = 1.0 g/cm3, αX is the LQ parameter of the X-Ray, and (yD)X is the dose mean lineal energy
for X-ray irradiation.
The saturation-corrected formulation of the MK model is one of the most widely used approaches
to estimate the RBE from microdosimetric measurements. Many studies have been published where
the computed RBE is compared with the RBE measured along single Bragg Peaks or more complex
mixed field irradiations [Rosenfeld, 2016, Guardiola et al., 2015, Kase et al., 2011, Bianchi et al., 2020].
In figure 7 the RBE vs. depth for a proton spread-out Bragg Peak is reported as an example of these
assessments [Bianchi et al., 2020].
Figure 6: Experimental α values, fitted by the linear-quadratic model from the survival curves of HSG
cells value with β0 = 0.05 Gy
−2, as a function of the dose mean lineal energy, yd. The yd were measured
by the TEPC with a simulated diameter of 1.0 µm. The solid line indicates the curve calculated using
equation (60) with the following model parameters: rd = 0.42 µm, Rn = 4.1 µm, α0 = 0.13 Gy
−1,
and β0 = 0.05 Gy
−2. Plot taken from [Kase et al., 2006].
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Figure 7: Clinical SOBP of CATANA. Dose profile measured with the Markus chamber in black, total
LET-dose from Geant4 MC simulation in blue. Crosses indicate positions at which both detectors
measured. The box reports the normalized spectra obtained with the mini-TEPC (black) and the
silicon telescope (red) at a depth of 29.08 mm. Plots taken from [Bianchi et al., 2020]
3.6 Track structure model incorporation in the MK model
In 2008, Kase et al. [Kase et al., 2007] introduced the usage of amorphous track structure mod-
els as an alternative numerical approach to evaluate theoretically the dose-averaged specific energy
deposition per event in the nucleus zn,D and in the domain zD for the MK model calculations. This
approach has the advantage of bypassing the necessity to acquire experimental lineal energy spectra
to evaluate the RBE; this approach is particularly useful when experimental spectra are not available,
such as in TPS calculations. Another interesting aspect is possibility to evince the dependence of
LET-RBE curves on the ion type.
The amorphous track model adopted for the MK calculation is based on a combination of the Kiefer
model for the penumbra region [Kiefer and Straaten, 1986] and the Chatterjee model for the core ra-
dius [Chatterjee and Schaefer, 1976], introduced for explaining the responses of the diamond detector
to heavy-ion beams [Sakama et al., 2005]. Here the core radius Rc (µm), the penumbra radius Rp
(µm) and the dose zKC as function of track radius r (µm) are evaluated as follows
Rc = 0.0116× βion (63)
Rp = 0.0616× (Es)1.7 (64)
zKC(r ≤ Rc) = 1
R2c
(
LET∞
rρ
− 2piKp ln(Rp/Rc)
)
(65)
zKC(r > Rc) = 1.25× 10−4(Z∗/βion)2r−2 (66)
where Es is the specific energy in MeV/u, Z
∗ is the effective charge given by the Barkas expression,
βion is the velocity relative to the speed of light, LET∞ is the unrestricted LET and ρ is the density
of water. In order to evaluate the dose-averages of the specific energies, the domain and nucleus are
assumed to have a cylindrical symmetry with the direction of the incident ion parallel to the cylinder
axis. Using this geometry is possible to write explicitly the dose average specific energy for a single
track (equation 12) for both domain and nucleus as
zD =
∫ bmax
0
zKC(b)
2b db
/∫ bmax
0
zKC(b)b db (67)
zn,D =
∫ b(n)max
0
zKC(b)
2b db
/∫ b(n)max
0
zKC(b)b db (68)
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where bmax and b
(n)
max are the maximum impact parameters to have a non negligible energy deposition in
the domain and in the nucleus respectively. These parameters, or equivalently the radius of the domain
rd and of the nucleus Rn, represents two parameters of the model. Examples of these evaluations are
shown in figure 8. Rn in principle it can be related to direct observations while rd does not represent
a measurable quantity, since it cannot be uniquely identified with any structure in the cell or cell
nucleus. rd can be used as a free parameter to be fixed by fitting the model to the experimental
survival and RBE data.
Figure 8: (a) and (b) Track structures for a carbon-ion beam with an energy of 50 MeV/u calculated
with the KieferChatterjee model and the corresponding specific energy z and saturation-corrected
specific energy zsat as functions of the impact parameter for domain and nucleus with different sizes.
(c) Schematic of an incident ion with respect to a cylindrical sensitive volume. Plots taken from
[Inaniwa et al., 2010].
Using the non-Poisson formulation for the biological effect as defined in (55) is possible to obtain
the corrected non-Poisson α coefficient as:
αNP ' (1− exp(−(α0 + β0zD)zn,D))
(
1
zn,D
)
(69)
According to [Hawkins, 2003], one can approximate zn,D =∝ LET∞/A , where LET∞ is the un-
restricted linear energy transfer in keVµm−1 for the incident particle and A is the area of the cell
nucleus in µm2, assuming ρ = 1 g cm−3 for the density of water. By assuming A = piR2n, equation
(69) becomes
αNP '
(
1− exp
(
−(α0 + β0zD)LET∞
ρpiR2n
))(
ρpiR2n
LET∞
)
(70)
No correction is considered for the β coefficient and it is still assumed to be independent on the energy
and particle type.
As seen in section 3.4 in the case of high LET irradiation the zD value is comparably very large with
respect to the (zD)X evaluated for photon; consequently, from Eq. 33 α0 and β0 can be approximated
with the experimental αX and βX . An example of the model evaluations compared to the experimental
data is reported in figure 9.
Interestingly, the explicit usage of a track model shows how some aspects of the MKM are con-
ceptually similar to that of the LEM [Scholz et al., 1997, Scholz and Kraft, 1992, Scholz and Kraft,
1996a, Elsa¨sser and Scholz, 2007, Elsa¨sser et al., 2008, Elsa¨sser et al., 2010, Friedrich et al., 2012a]. In
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Figure 9: Global fitting of the MK model to experimental RBEα data for different ion irradiation
subsetted from the PIDE database [Friedrich et al., 2012b] with R = αX/βX ∈ [2.8, 3.2] Gy. The
plotted points indicate the experimental results and the lines represent the MKM results calculated
with the KieferChatterjee track structure model. The bands represent the 90% confidence band
obtained from the MK model parameters {α0, β0, Rn, rd} probability distribution, evaluated through
a bootstrap procedure.
both MK model and LEM the principal target is the cell nucleus for any radiation quality, the nucleus
is divided into small independent sub-volumes (infinitesimal volumes in the case of LEM and domains
in the case of MK model) and a cell survival curve for x-rays is adopted as the local dose-effect curve of
each sub-volume. Finally the summation of the local effect in all sub-volumes over the whole nucleus
determines the cell survival probability.
The inclusion of the amorphous track model allow to evaluate directly zD and zn,D without the
necessity to obtain these values by extrapolating them from microdosimetric measurements via scaling
relationships such as equation (19). This aspect can be particularly advantageous for some applica-
tions where these spectra are generally not easily or partially available such as in the simulation and
optimization of treatments in TPS applications, where the biological effect should be evaluated in the
whole irradiated 3-D patient volume.
At present the MK model is implemented in the proton and carbon ion TPS used clinically at
the National Institute of Radiological Sciences (NIRS) in Japan to evaluate the RBE and the RBE-
weighted dose optimized for the individual patients. The computation method, developed by Inaniwa
et al. [Inaniwa et al., 2010, Inaniwa et al., 2015a] takes advantage of the incorporation of the amorphous
track model in combination with the saturation corrected approach developed by Kase et al. [Kase
et al., 2006] described in section 3.5, for evaluations in case of mixed field irradiation. In the TPS
implementation a set of pre calculated look-up tables of the saturation corrected specific energies for
monoenergetic beams are created using a generalization of equations (67)-(68) where the saturation
effect is explicitly included for the dose averaged specific energy for the domain
z∗D =
∫ bmax
0
zsat(b)zKC(b)b db
/∫ bmax
0
zKC(b)b db (71)
and equivalently for the nucleus, where zsat is the saturation-corrected specific energy
zsat(b) =
z20
zKC(b)
(
1− exp
(
−zKC(b)
2
z20
))
(72)
with saturation coefficient z0 = y0(l¯d/md) (see equation 61) evaluated in the cylindrical geometry
(see also panel (c) of figure 8). The effect of the mixed-field of the treatment at a position is hence
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evaluated through a dose-weighted linear combination
(z∗D,mix)i =
∑Nb
j=1Dij(z
∗
D)ij∑Nb
j=1Dij
(73)
where Nb is the number of beams of the treatments, Di,j is the dose released at position i by the beam
j, and
(z∗D)ij =
∑Nij
k=1 ek(z
∗
D)k∑Nij
k=1 ek
(74)
is the saturation-corrected dose-mean specific energy of the domain of cells at position i delivered by
the jth beam, obtained through the mono-energetic evaluations, (z∗D)k, described in equation (71). To
obtain the energy imparted ek and the number Nij of the deposition events, Monte Carlo simulations
are used, taking advantage of available codes such, as example, those derived from the Geant4 libraries
[Agostinelli et al., 2003, Aso et al., 2007, Zhu et al., 2019] and Fluka [Magro et al., 2017].
3.7 The dependence of the biological effect on the dose-rate time structure
One of the interesting features of the MK model, in contrast to other radiobiological models used in
hadrontherapy such as the LEM, is the possibility to account inherently for arbitrary time dependent
dose-rates, such as protracted irradiations and fractionations. This feature derives from the explicit
description of the time depending response of the cell to the irradiation trough the kinetic equations
(Eq. 29).
Different approaches to investigate and to model the dose-rate time effects have been carried
out using the MK model as a theoretical base. Some examples of these approaches can be found in
[Hawkins, 1996, Inaniwa et al., 2013, Hawkins and Inaniwa, 2013, Hawkins and Inaniwa, 2014, Inaniwa
et al., 2015b, Manganaro et al., 2017, Matsuya et al., 2018a]. In these studies, the kinetic equations
(24) are slightly generalized to account an arbitrary time dependent specific energy deposition rate
z˙(c,d) in the domains: x˙
(c,d)
I = λz˙
(c,d) + ax
(c,d)
II + b
(
x
(c,d)
II
)2
,
x˙
(c,d)
II = κz˙
(c,d) − (a+ r)x(c,d)II − 2b
(
x
(c,d)
II
)2 ' κz˙(c,d) − (a+ r)x(c,d)II . (75)
where in the second equation, as described in section 3.2, the second order process describing the
pairwise combination between type II lesions has been removed since it is considered negligible if
compared to the first-order process.
In [Inaniwa et al., 2013] and [Inaniwa et al., 2015b], the effects of dose-delivery time structure
on the RBE in a mixed radiation fields of therapeutic carbon ion beams is investigated using by
the modified microdosimetric kinetic model introduced by Kase et al. [Kase et al., 2006, Kase et al.,
2007, Inaniwa et al., 2010]. The study evaluate the biological effect of the irradiation in two different
dose-rate conditions: a split-dose irradiation and a protracted continuous irradiation.
In the case of a split-dose irradiation, a population of cells is considered exposed to a macroscopic
dose D1 at time t = 0 and a dose D2 at time t = ∆T , where a domain absorbs z1 and z2 from the
two separate irradiation respectively. Evaluating xI in the limit t → ∞ by integrating the equations
(24) and using the saturation correction specific energy as given in equation (59), we obtain for the
cell survival:
lnS(D,∆T ) =− (α0 + β(z∗D)1)D1 − βD21 − (α0 + β(z∗D)2)D2 − βD21
− 2βD1D2e−(a+c)∆T 1− e
−2(a+c)(tr−∆T )
1− e−2(a+c)tr
(76)
where (z∗1D)1 and (z
∗
1D)2 are the saturation corrected dose means of the first and second irradiation
and the total dose D = D1 + D2. The time parameters tr indicates the the time after which all
sub-lethal lesions that are not still repaired are fixed in lethal lesions, according to assumption (9)
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introduced in section 3.2. If the quality of the radiation does not change between the two irradiations
then (z∗D)1 = (z
∗
D)2 = z
∗
D and Eq. 76 can be simplified as
lnS(D,∆T ) =− α0 (D1 +D2)− z∗1Dβ (D1 +D2)− β (D1 +D2)2
+ 2βD1D2
[
1− e−(a+c)τ
(
1− e−2(a+c)(tr−τ))(
1− e−2(a+c)tr)
]
(77)
The values of (a + c) and tr can be determined by using the following approximations (see Eqs. 35,
40 in [Inaniwa et al., 2013]):
(a+ c) ∼= 1
2βD1D2
[
1
S
dS
dτ
]
τ=0
(78)
tr = − ln(α/κ)
(a+ c)
(79)
In the case of a continuous protracted irradiation, a population of cells receive a constant macroscopic
dose rate of D˙ starting at time t = 0 and ending at t = T . In order to carry out the evaluation, the
irradiation is assumed microscopically equivalent to a number N of instantaneous irradiations with
random doses to a domain delivered every infinitesimal interval. The time interval between these
irradiations is δt = T/(N − 1), with δt 1/(a+ c), and each domain absorbs z1 , z2 , . . . , zN . The the
number of lethal lesions per domain xI is therefore obtained by integrating and summing the solution
of Eq. 24 for each time segment. The final cell survival probability is then obtained by introducing
the corresponding saturation corrected dose means in a way analogous to the split dose evaluation.
In the case in which the quality of the radiation does not change with time, the final log survival is
given as:
lnS = − (α0 + β0z∗d,D)D − β′D2 (80)
where
β′ ≡ β0
1− 2
N2
N−1∑
n=1
(N − n)
1− e−(a+r) ~N−1T
(
1− e−2(a+r)(tr− nN−1T)
)
(
1− e−2(a+r)tr)

 (81)
The notation used in Eqs. 80 and 81 highlights the importance of the quadratic term β, which modu-
lates the impact of the dose-rate time structure, according to the LQ interpretation of the biological
effects [Deehan and O’Donoghue, 1988, Fowler, 1989, Yaes et al., 1991, McMahon, 2018].
It is worth remarking that these MK-based temporal formulations of the cell survival derived from
the kinetic equations (75) do not accounts for re-population and cell cycle redistribution. Figure 10
reports the evaluation via equation (77) of the survival fraction of HSG cell line for various time
intervals compared to experimental data. An initial rise in cell survival due to repair is visible until
time interval ∆T = 0.75 h followed by a decrease in survival due to cell cycle redistribution and a rise
due to re-population (1.4 < ∆T < 4 h ) and by the saturation region for ∆T > 4 h. The predicted
cell survivals reasonably agrees with data in the first and last regions, while it does not accounts for
re-population and redistribution. The temporal formulations described in this section have been also
incorporated in the TPS used at NIRS [Inaniwa et al., 2010] (see also section 3.6), and successfully
used to estimate the impact of the beam interruption in single-fractionated treatments with carbon
ions for patients with prostate tumor [Inaniwa et al., 2015b].
3.8 Stochastic approaches and variable β
As discussed in the previous sections, the MK model accounts for the stochastic aspects of the
induction of damage in the cell by exploiting probability theory to develop simple formulas for the
LQ coefficients of the cell survival [equations (41), (42), (55), (59), and (80)]. These formulations of
the model are obtained introducing approximations [Hawkins, 2003] or ad-hoc corrections [Kase et al.,
2006] that shows some discrepancies with experiments for high-LET irradiation, in particular in the
determination of the β coefficient, since the measured β tends to decrease at very high LET [Furusawa
et al., 2000, Czub et al., 2008, Tsuruoka et al., 2005, Friedrich et al., 2012b], while the β derived from
the MK model is considered constant.
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Figure 10: Survival fraction of HSG tumor cells after exposure to two equal doses of carbon beams
with D1 = D2 = 2.5 Gy separated by time interval τ (∆T in the text) from 0 to 9 h. Three different
series of experiments (runs) are shown. The estimated tangent at τ = 0 h is reported in dashed line,
while the solid curve is the predicted survival by Eq. (77) with β = 0.0703 Gy−2 , β = 0.237 Gy−2,
(a+ c) = 2.187 h−1 and tr = 2.284. Plot taken from [Inaniwa et al., 2013].
The disagreements in the β coefficient are ultimately acknowledged to be induced by the partial
accounting of the stochastic nature of the specific energies in the MK model calculations that plays an
important role for high-LET irradiation [Sato and Furusawa, 2012]. Following these considerations,
attempts to improve the model, introducing more refined approaches to account a variable β, have been
made [Sato and Furusawa, 2012, Manganaro et al., 2017, Chen et al., 2017, Inaniwa and Kanematsu,
2018]. In the rest of this section some of these developments, based on improved stochastic modelings
of the specific energy depositions, are described in details.
3.8.1 Monte Carlo based evaluations
A method to account in a natural and straightforward way the inherent stochastic nature of
the irradiation is to implement a Monte Carlo algorithm in the MK model, as recently shown by
Manganaro et al. [Manganaro et al., 2017, Manganaro et al., 2018] in their formulation of the model
named MCt-MKM (Monte Carlo temporal microdosimetric kinetic model). The implemented model
accounts also the stochastic temporal correlations characteristic of the irradiation process and the
cellular repair kinetics by solving explicitly in the MC evaluations the kinetic equations (75) where
the time dependent specific energy rate z˙(c,d) appears explicitly [Inaniwa et al., 2013, Hawkins, 2017].
In the MC approach the irradiation of a complete population of Nc cells is simulated, where Nc is
supposed to be large enough in order to achieve statistical convergence. The irradiation is modelled
as an ordered temporal sequence of particles (primaries and secondaries) that interact with the cell
nucleus at random spatial coordinates and random times t
(c)
0 ≤ t(c)1 ≤ t(c)2 ≤ . . ., compatible with the
chosen irradiation setting and the definition of the time-dependent macroscopic dose rate D˙(t). The
irradiation is hence modelled as a sequence of spikes in z˙(c,d)(t), each one of them corresponding to the
passage of a particle through or nearby the nucleus, delivering a sequence of random specific energies
in the domains
z
(c,d)
0 (t0), z
(c,d)
1 (t1), z
(c,d)
2 (t2), . . . (82)
depending on the particle spectra and track impact positions with respect the cell. A depiction of
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the temporal evolution of the lesions (xI and xII) due to the effects of the irradiation as described in
equation (82) is reported in panel (b) of figure 2. For a macroscopic dose D and a specific component
e of the energy and particle type spectra, the total number of particles Ne interacting with the nucleus
follow a Poisson distribution with mean
N¯e =
ρσDwe
LETF
(83)
where LETF is the frequency-mean LET of the radiation, σ is the cross section of the nucleus, ρ is
the density of the tissue, and we is the weight of the component e.
In principle, the tracks can directly sampled from the full measured microdosimetric spectra (i.e.
not only the first and second moment) from which the experimental we can be obtained. From a
practical point of view, the specific energies deposited randomly in each domain of each nucleus are
evaluated by coupling general purpose MC tools (such as Geant4 [Agostinelli et al., 2003] or Fluka
[Ferrari, A. Sala, P.R. Fasso, A. Ranft, 2005]), used to evaluate the spatio-temporal energy and particle
type spectra in a specific irradiation configurations, with the amorphous track model, as described in
[Kase et al., 2007, Inaniwa et al., 2010], with domains arranged according to a close packing hexagonal
structure inside the nucleus.
Once the sequence of specific energies in the domains (82) are obtained, the kinetic equations (75)
can be formally solved for t→∞ to obtain the average lethal lesions for each cell-domain (c, d):
− log s(c,d) = x(c,d)I
∣∣∣
t→∞
=
α0
Nd
nc−1∑
i=0
z
(c,d)
i +Gc,d
β0
Nd
(
nc−1∑
i=0
z
(c,d)
i
)2
(84)
where nc is a Poisson random variable indicating the number of particles that interacted with the
cell c, τ = 1/(a + r) is the time constant that defines the first order repair kinetics, and G is the
generalized Lea-Catcheside time factor [Lea and Catcheside, 1942, Kellerer and Rossi, 1972] defined
at the nanodosimetric level of the domain:
G(c,d) = 1− 2(∑nc−1
i=0 z
(c,d)
i
)2 nc−2∑
i=0
nc−1∑
j=i+1
(
1− e−
1
τ
(
t
(c)
j −t(c)i
))
z
(c,d)
i z
(c,d)
j (85)
The survival fraction S is obtained by averaging over the entire cell population the survival prob-
ability evaluated for each single cell Sn(c) (see for comparison equations (34) and (38))
S(D) = 〈S(c)n ;D〉c =
〈
exp
(
−
Nd∑
d=1
x
(c,d)
I
)〉
c
= Nd〈−〈x(c,d)I 〉(c)d 〉c (86)
Notice that the Monte Carlo approach does not compute directly the LQ coefficients α and β, in
contrast the analytical approaches described in the previous sections. However is possible to derive
the LQ coefficients by simulating a complete survival curve, i.e. by evaluating (86) using different
macroscopic doses D1 < D2 < D3 < . . ., and then fitting the curve with the LQ formula. An example
of a complete simulated survival curve is reported in figure 11. We remark also that, as done in section
3.7, the cell population generated by the solutions of the kinetic equations (75) neglects re-population
and cell cycle re-distributions.
One of the benefits of the MCt-MKM approach is that both α and β coefficients, obtained through
the survival fitting, show the expected saturation behaviour for high-LET irradiation without adding
any corrective factors, like the non-Poisson (section 3.4) or (section 3.5) saturation. The disadvantage
of the approach, other than the inherent approximations specific to the used MC transport code and
the adoption of an amorphous track model, is that it can be particularly computing intensive, although
this is mitigated by exploiting the multi-core parallelism of modern CPUs [Manganaro et al., 2018].
The MCt-MKM has been validated on in-vitro experiments considering acute and split-dose irra-
diation on HSG, T1 and V79 cell lines in aerobic conditions of H, He, C and Ne ion beams [Manganaro
et al., 2017]. An example of the behaviour of the LQ α and β coefficients is reported in figure 12,
where also a comparison with the prediction of other models, a non-stochastic MKM evaluation, the
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Figure 11: Simulated survival curves obtained for acute irradiation, (t0 = t1 = t2 = . . .), of mo-
noenergetic carbon ion (8 MeV/u) with imposed macroscopic doses ranging from 0.1 to 8 Gy. The
dots represent the values of cell survival S
(c)
n (z
(c)
n ) and specific energy z
(c)
n = Nd
∑Nd
d=1
∑(nc−1)
i=0 z
(c,d)
i
delivered in the cell c (a small dot for each simulated cell); the variability of the delivered dose with
respect to the imposed dose derives by the fluctuation determined by the MC simulation. The two
curves were fitted using the LQ model (solid and dashed lines respectively) in order to get the LQ
parameters. The blue curve is fitted directly to the S
(c)
n (zn) data, and correspond to the Poisson
approximation described in equation (40). The black line correspond to the fit to the population
averages 〈S(c)n ;D〉c defined in equation (86) for each imposed dose D (open dots) and correspond to
the non-Poisson formulation of equation (69). Plot taken from [Russo, 2011].
LEM and the he Repair-Misrepair-Fixation (RMF) model (see section 4.2), is shown. The main differ-
ence with respect to the original MKM is that the MCt-MKM predicts a non constant and vanishing
β with high LET values. This behaviour is ultimately due to the non-Poisson statistics inherently
implemented in the model.
The model was also implemented in a TPS [Russo et al., 2015] to evaluate the effect of the
temporal protraction of treatments with different ion beams. The effect of the protraction, described
microscopically by the equation (85), was shown to be compatible with a macroscopic first order effect
with temporal constant τ [Manganaro et al., 2017]. We remark that, in the framework of the LQ
formalization, in the studies of high dose irradiation and the dose-rate effect, such as those reported
in [Inaniwa et al., 2013, Inaniwa et al., 2015b, Hawkins and Inaniwa, 2013, Hawkins and Inaniwa,
2014, Manganaro et al., 2017], the specific way β is modeled plays a fundamental role [Fowler et al.,
2004, Carabe-Fernandez et al., 2010]. In particular, the behaviour of a vanishing β for high LET
is compatible with the experimental observation of a reduction of the sensitivity to the dose rate
(including the fractionation) in healthy tissues for treatments with high-LET ions, and hence the
potential advantage of hypofractionated treatments with these particles.
3.8.2 The stochastic microdosimetic kinetic model
The analytical computation method proposed by Sato and Furusawa in [Sato and Furusawa, 2012]
introduces a correction to the original formulation of MK model, taking into account the stochastic
nature of specific energy deposition in both the domain z and the cell nucleus zn, to improve the
adherence of the model to the measured survival fractions for high-LET and high-dose irradiation.
The new model is named double-stochastic micro-dosimetric kinetic (DSMK) model. In the same
study [Sato and Furusawa, 2012], a second model, termed stochastic microdosimetric kinetic (SMK)
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Figure 12: Linear quadratic α (panel a) and β (panel b) parameters as a function of LET for the
irradiation of of V79 cells with different ions. Points represent experimental data taken from PIDE
[Friedrich et al., 2013b], different colors/gray levels and shapes refer to H, He, C and Ne ions re-
spectively (the colour/gray level and shape legend refers both to panel a and b). In panel a, solid
and dashed lines represent respectively the extrapolation with the MCt-MKM and the original MKM
models, while in panel b a comparison between different model is reported (namely MKM, MCt-MKM,
LEM-II and RMF). In the case of the MCt-MKM, overlapped to the α and β curves the MC statistical
confidence bands (68%) are reported. These bands are small due to the high statistics and they blends
with the curves thickness. A saturation effect is observed for both α and β parameters. Plot taken
from [Manganaro et al., 2017].
model, is derived to represents the stochastic nature of domain specific energy z by its approximated
mean value and variance in order to reduce the computational time.
Based on radiobiological evidences that states that DNA damage saturates at high-LET regions
[Friedland et al., 2006, Hada and Georgakilas, 2008], the original assumption of the MKM, that the
initial numbers of lethal and sub-lethal lesions produced in a domain to be proportional to the specific
energy in the site, is changed in the DSMKM assuming that the initial numbers of lethal and sub-lethal
lesions produced in a domain are proportional to the saturation-corrected specific energy, z∗ in the
domain, calculated as:
z∗ = z0
√
1− exp
[
− (zd/z0)2
]
(87)
where z0 can be obtained from z0 = y0(l¯d/md) with the saturation correction parameter y0 defined in
equation (61) and with dose average z∗D, the saturation correct dose averaged specific energy introduced
in equation (58).
By applying this new parameter, the natural logarithm of survival for a domain and the nucleus,
equation (32) and (34), can be rewritten respectively as:
log (s (z)) = −Az∗ −Bz∗2
log (Sn(zn)) = −α0
∫ ∞
0
z∗f(z; zn) dz − β0
∫ ∞
0
z∗2f(z; zn) dz
(88)
with the natural log of the survival fraction of cell irradiated with dose D, logS(D) = 〈Sn〉c given by
substituting equation (88) in equation (38).
The evaluation of the multi-event probability density f(z; zn) is obtained numerically by applying
a general n−fold convolution method such as the one presented in section 2 (equations (4) and (6))
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to the single event probability density f1(z). The evaluation of f1(z) is performed exploiting a micro-
dosimetric function implemented in the PHITS Monte Carlo code [Sato et al., 2018, Iwamoto et al.,
2017]. The sum in equation (6) can be truncated for practical purposes, with 100 events being enough
to evaluate the density probability function of cells with zn = 100.
The same approach is used to calculate the multi-event probability density of the cell nucleus
specific energy, for an absorbed macroscopic dose D, fn(zn, D) from the single event function fn,1(zn).
However, since the nucleus radius is over the available range of the microdosimetric function imple-
mented in PHITS, fn,1(zn) is determined from the frequency distribution of the LET L, FL(L):
fn,1(zn) =
∫ ∞
0
FL(L)fn,1(zn, L) dL (89)
where fn,1(zn, L) represents the probability density of zn from a particle with LET = L. Following
the formalism carried out in [Olko and Booz, 1990], the expression for fn,1(zn, L) is written as a Fermi
function:
fn,1 (zn, L) =
2C
(Lη)2
zn
exp [(zn − Lη) /γ] + 1 (90)
where C is a normalization constant and η is a units conversion coefficient. The parameter γ tunes
the slope of the Fermi function or, equivalently, the magnitude of the fluctuation of zn due to the
straggling.
Once fn,1(zn) is determined, the multi-event function fn(zn;D) for the nucleus is obtained with the
same n-fold convolution procedure used in the case of f(z; zn). In this case however, due to the higher
average number of events that can happen in the nucleus compared to the domain, λn(D) λ(zn), the
computation is significantly more demanding and cannot be practically used for applications inherently
complex such as TPS evaluations for ion beam treatments. To overcome this problem, in the case of
high-dose irradiations, a pre-evaluated database of probability densities derived from mono energetic
irradiations are used and combined in a central limit approximation.
To overcome the long computational time of DSMK model in a TPS workflow a further optimization
is performed for the computation of the survival in (88) that bypass the necessity to compute the n-fold
convolution integral (equation 6). In this formulation of the model (SMK) is assumed that saturation
effect triggered by multiple hits of radiations to a domain is negligibly small so that the magnitude
of the effect for the n-event energy deposition can be derived from the estimate with the single event
density probabilities (see also equations (9) and (12)):∫∞
0 z
∗f(z, z) dz∫∞
0 zf(z, z) dz
=
∫∞
0 z
∗f1(z) dz∫∞
0 zf1(z) dz
=
z∗F
zF
(91)
and ∫∞
0 z
∗2f(z, z) dz∫∞
0 z
2f(z, z) dz
=
∫∞
0 z
∗2f1(z) dz∫∞
0 z
2f1(z) dz
=
z∗D
zD
(92)
The natural log of the survival fraction of a cell can be calculated by substituting equations (91) and
(92) in equation (88) obtaining
log (Sn (zn)) = −α0zn z¯
∗
F
zF
− β0
(
zDzn + z
2
n
) z∗D
zD
(93)
In order to reduce further the computational effort for TPS applications, assuming that in standard
condition of charged-particle therapy the events inducing the saturation of complex DNA damages are
rare, and hence z∗F /zF ≈ 1, the following approximation of equation (38) was derived [Inaniwa and
Kanematsu, 2018],
logS(D) = log
{
1 +D
[
−βSMK + 1
2
(αSMK + 2βSMKD)
2
]
zn,D
}
− αSMKD − βSMKD2 (94)
with
αSMK := (α0 + z
∗
Dβ0) (95)
βSMK := β0(z
∗
D/zD) (96)
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Figure 13: The measured survival fractions of HSG cell exposed to 3He- (a)(c), 12C- (d)(f) and
20Ne-ion beams (g)(i) at different LETs reported by Furusawa textitet al. [Furusawa et al., 2000]
(dots), compared with the estimations based on the modified SMK (solid curves) and the MK (dashed
curves) models. Experimental data taken from [Furusawa et al., 2000]. Plot taken from [Inaniwa and
Kanematsu, 2018]
Both DSMK and SMK models can reproduce the measured survival fractions, even for high-LET
and high-dose irradiations, whereas the simple saturation-based MK model [Kase et al., 2006] predicts
lower values for these irradiations due to the intrinsic ignorance of the stochastic nature of the cell
nucleus specific energies (see figure 13). In particular, the DSMK model can account for the decrease
in the β parameter observed in high-dose irradiations over 10 Gy due to the saturation effect triggered
by multiple hits of radiations to a domain.
3.9 Extensions and further improvements of the MK model
In recent years, a number of studies have been published reporting further refinements and ex-
tensions of the MK model. Among these are further improvement accounting of the non-Poissionian
statistics [Abolfath et al., 2017, Inaniwa and Kanematsu, 2018], the inclusion of an explicit DNA mod-
eling [Matsuya et al., 2014, Chen et al., 2017], the effect of a heterogeneous cell population including
the cell-cycle variance [Hawkins, 2000, Hawkins, 2017, Matsuya et al., 2018a], and the inclusion of
non-target effects [Matsuya et al., 2018b]. Extension of the model have been also proposed to compute
quantities beyond the RBE, such as the oxygen ehancement ratio (OER) [Bopp et al., 2016, Strigari
et al., 2018]. In the following of this section, some details about a selection of these developments are
described.
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3.9.1 Oxygen enhancement ratio (OER) modeling
Several experimental evidences that cellular oxygenation condition strongly affects their response
to ionizing radiation. In particular, a significantly lower cell death rate is observed after exposure to
ionizing radiation in the presence of a reduced concentration of oxygen in the cells, i.e. in hypoxic
conditions. As clinically observed, solid tumours can contain oxygen-deficient regions, thus increasing
their radioresistance and potentially leading to treatment failure [Thomlinson and Gray, 1955, Hockel
et al., 1993]. An understanding of why high-LET radiations are so effective at overcoming tumor
hypoxia [Ito et al., 2006, Nakano et al., 2006] is also particularly relevant for the individualization and
optimization of hadron therapy. For this purpose, attempts to extend the MK model to describe the
dependence of the the radiation effects on the oxygen concentration in cells and to model the oxygen
enhancement ratio (OER) have been made [Bopp et al., 2016, Strigari et al., 2018].
It this interesting to note that these MK model-based approaches, although different, do not
focus on OER modeling, a relative value, but directly on the prediction of hypoxic cell survival data,
being the OER a derived quantity. In [Bopp et al., 2016] the reduction of lethal (xI) and potentially
lethal (xII) damage is linked in the low-LET region to the phenomenological photon OER, though the
modulation of parameters λ and κ (equation 25) and the effective sizes of domain and nucleus, with the
Alper and Flanders functional formalism [Alper and Howard-Flanders, 1956] the introduce formally
the Oxygen concentration dependence in the moedl. In [Strigari et al., 2018] the general approach
proposed by Wenzl and Wilkens [Wenzl and Wilkens, 2011] has been adapted to the amorphous track
approach to the MK model [Kase et al., 2007] (the latter described in section 3.6). The inclusion of
track model ultimately brings to the OER an explicit dependence on ion type while the Wenzl and
Wilkens formalism brings and explicit dose and Oxygen concentration dependence int the alpha and
beta parameters. These characteristics have been exploited, by integrating the model in a TPS, to
evaluate the tumour control probability (TCP), to facilitate the identification of the optimal treatment
conditions in term of ion choice and dose fractionation in presence of hypoxia.
The MK-based OER models were verified against in-vitro data from HSG, V79 and CHO cells in
aerobic and hypoxic conditions, irradiated with different ion beams [Furusawa et al., 2000]. Examples
of the model prediction versus the experimental data are reported in figure 14.
3.9.2 Non-targeted effects
In the majority of cell survival modeling approaches it is assumed that biological effects of radia-
tion are exclusively due to direct DNA damage resulting from the ionization caused by the incident
radiation. In recent years this assumption has been extensively challenged by considering a variety of
indirect processes, also referred as bystander or non-targeted effects (NTE), that significantly impact
on the cellular response to the radiation [Mothersill and Seymour, 2001]. NTEs have been inter-
preted as a result of intercellular communication with cell-killing signals between hit and non-hit cells
[HAMADA et al., 2007, Hamada et al., 2012] resulting in induced DNA damage in non-hit cells [Hu
et al., 2006].
Attempts to derive kinetic equations to model the intercellular signalling which incorporates signal
production and response kinetics have been made [McMahon et al., 2013, Kundra´t and Friedland,
2015, Mcmahon et al., 2016]. In recent studies, such as in Matsuya et al. [Matsuya et al., 2018b], an
integration of these signalling kinetic equations in the MK model, has been proposed.
In this formulation, denoted integrated MK (IMK) model, the number of signalling activation
events, NNT, in the domain is assumed to be a linear-quadratic function of the specific energy z.
Thus, following the same procedure and the assumption of a Poisson statistics used to derive equations
(41)-(42), the dose dependent fraction of receiving cells that are activated is written as:
fNT(D) = 1− e−〈NNT〉c = 1− e−(αNT+zDβNT)D+βNTD2 , (97)
where αNT and βNT are the LQ coefficients of the signal activation process. The propagation of the
cell-killing signal is modeled as a diffusion process with diffusion constant θ and a simple exponential
decay with a rate constant λ. The signal concentration ρs(r, t), where r is a spatial position and t is
time, can hence be obtained by solving the continuity equation:
∂ρs(r, t)
∂t
= θ∇2ρs(r, t)− λρ(r, t) . (98)
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Figure 14: (a) D10% values for oxic (closed symbols) and extremely hypoxic (open symbols) V79
cells as a function of dose-averaged LET [Furusawa et al., 2000]. The lines represent the MK model
calculations (solid lines) and the hypoxia-adapted MK model calculations with parameters optimised
for the V79 cell line (dashed lines). Plot from [Bopp et al., 2016]. (b) The OER as a function of
the dose-averaged LET for the irradiation of HSG cells with different ions. The points represent the
experimental data taken from Furusawa et al. [Furusawa et al., 2000]. The continuous lines represent
the OER simultaneously evaluated by means of the MKM-based model for He, C and Ne. In the same
plot, the OER calculated by other models is reported for comparison (non-continuous lines). The
model by Scifoni et al. [Scifoni et al., 2013] is associated with carbon ions only, while the model by
Wenzl and Wilkens [Wenzl and Wilkens, 2011] is not associated with any specific ion. An evaluation
with the model proposed in Antonovic et al. [Antonovic et al., 2013] is also shown. Plot taken from
[Strigari et al., 2018].
In non-hit cells the NTE sub-lethal lesions [xII ]NT are assumed to be induced in proportion to the
signal concentration ρs(r, t) and then converted to lethal lesions xI with the same constant rate a of
equations (24) so that the number of sub-lethal lesion is written as:
[x˙II(r, t)]NT = (1− fNT(D))[xII(r, t)]NTκNTRNTρs(r, t)− (a+ rNT)[xII(r, t)]NT , (99)
where RNT is the constant rate for cell-killing signals reacting with the nucleus of non-hit cells, κNT is
the number of sub-lethal lesion per domain caused by the signals, and rNT is a constant rate for repair
in non-hit cells (in general rNT 6= r, i.e. the repair rate in targeted cells). In [Matsuya et al., 2018b]
the following functional form for the cell surviving fraction by the NTE (SNT) has been proposed as
an approximate solution of the previous equations
logSNT = −〈[xI,n]NTE〉c = −δ
(
1− e−(αNT+zDβNT)D+βNTD2
)
e−(αNT+zDβNT)D+βNTD
2
(100)
where δ is a function of the other parameters introduced in the former equations that characterize the
intercellular signalling process.
In order to practically compute the total cell survival S, which includes both targeted and NTEs,
it is assumed that the probability of interaction between sub-lethal lesions xII and [xII ]NT in the
domain is negligible. This assumption factorizes the two system of equations (24) and (99), and hence
considers the total cell survival as the product of S = ST×SNT, where the survival for targeted cells,
ST, is given by equation (40). Figure 15 shows an example of the fitting of the IMK model with
experimental clonogenic data. It is interesting to note the possibility of the IMK model to account
for deviations from the LQ formalism, reproducing the low-dose hypersensitivity behaviour of cell
response and evincing its relation with DNA repair mechanisms.
4 Other models
This section presents alternative models to determine RBE based on microdosimeric approaches.
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Figure 15: (a) Comparison between the IMK model (Eq. 100), continuous gray line in the plot, and
experimental medium transfer bystander effect (MTBE) cell survival data. (b) Fitting of the IMK
model to experimental cell survival data for V79-379A. Plot taken from [Matsuya et al., 2018b] (
http://creativecommons.org/licenses/by/4.0/ )m
4.1 RBE weighting functions
The microdosimetric RBE-weighting function approach has been proposed initially by Menzel,
Pihet, Wambersie et al. [Pihet et al., 1990, Menzel et al., 1990, Wambersie, 1994, Wambersie et al.,
1990] to compare the beam quality of different neutron [Pihet et al., 1990] and proton [Robertson et al.,
1994, Coutrakon et al., 1997] therapeutic installations using measured microdosimetric distributions
of lineal energy. Based on previous studies on proton beams [Kliauga et al., 1978, Hall et al., 1978],
this approach uses measured microdosimetric distributions of lineal energy, y, combined with an
experimental derived biological weighting function, for specific cell line and endpoints, r(y), to evaluate
the RBE.
Let P (y) be the cellular response function for a population suffering the fraction of dose d(y)dy
corresponding to the lineal energy y. d(y) is the dose probability density of y and can be evaluated as
d(y) = yy¯F f(y) [Booz et al., 1983]. The linear α parameter, interpreted as the biological effect E per
unit dose, is expressed as:
α = E/D =
∫
P (y)
y
d(y) dy ≡
∫
r(y)d(y) dy (101)
where r(y) is defined as the response function. Therefore, the model is rigorously valid under the
assumption if a low dose approximation where the cellular response function is linear.
P (y) or directly r(y) are experimental derived. A formulation for r(y) is given in the following
[Paganetti et al., 1997, Morstin et al., 1989]
r(y) = σE(1− exp
(−a1y − a2y2 − a3y3) /y , (102)
where the σE , a1, a2 and a3 are parameters specific of the radiobiological end points and are inde-
pendent on the quality of the radiation. These parameters are determined experimentally by fitting
a set of different measurements of αi or RBEα,i = αi/αX using different irradiation modalities with
different radiation qualities i = 1, 2, 3, . . . , N .
[Paganetti et al., 1997, Morstin et al., 1989]. The set of relations that have to be fitted is hence
RBEα,i =
∫
r(y)di(y) dy; i = 1, . . . N (103)
The solution of the system of Eq. 103 can be obtained with different methods, such as non-parametric
multi-objective optimization methods [Olko, 1989] or iterative procedures [Loncol et al., 1994] through
which an initial guess function r(y) is iteratively updated to best fit the Eq. 103.
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4.2 The Repair-Misrepair-Fixation (RMF) model
The Repair-Misrepair-Fixation (RMF) model combines the RMR and LPL models adding the
consideration of intra- and intertrack† binary misrepair to predict the biological effect of LET [Carlson
et al., 2008, Frese et al., 2012, Stewart et al., 2018]. The RMF model considers the entire cell nucleus as
the volume for pairwise DSB interactions. In the RMF model a coupled system of nonlinear ordinary
differential equations is used to model the time-dependent kinetics of DSB induction, rejoining, and
pairwise DSB interaction to form lethal (and nonlethal) chromosome damage. The model treats initial
DSB formation as a compound Poisson process and postulates a first-order repair term that gives rise
to exponential rejoining kinetics for most DSB (> 98%) and a second-order (quadratic) term to account
for the small subset of the initial DSB (< 2%) that undergo pairwise DSB interactions to form an
exchange.
A LQ approximation of the solution of the RMF system of differential equations can be expressed
as follows [Carlson et al., 2008, Frese et al., 2012]:
RBEα =
Σ
ΣX
(
1 +
2
RΣX
(Σzn,F − ΣX(zn,F )X)
)
(104)
RBEβ =
Σ
ΣX
, (105)
where Σ is the initial number of DBS per Gray per giga base pair (Gy−1Gbp−1) and zF,n is the
frequency-mean specific energy evaluated in the nucleus (see Eq. 9), for the particle radiation. The
suffix X indicates the same quantities for the reference photon radiation. RBEα, RBEβ and R are
defined in Eq. 48, while the ratio Σ/ΣX = RBEDSB can be interpreted as the RBE for DSB induction.
From Eq. 104 it follows that the radiation response of a cell exposed to a radiation is uniquely
determined by one microdosimetric parameter (zF,n) and two biological parameters (RBEDSB) and
R. zF can be derived form microdosimetric measurements or computed via Monte Carlo simulations.
Implicit in the determination of zF is the knowledge of the size of the nucleus. For a spherical
water target of diameter d, the frequency-mean specific energy can be approximated by Eq. 20. A
complication arises from the fact that, in general, RBEDSB also strongly depends on particle type and
kinetic energy (and thus LET or lineal energy) although it is considered to be the same among all
eukaryotes. Consequently, R is basically left as the main parameter of the RMF needed to discriminate
the radiation response among different cell lines (compare also the MK model formulation, equation
(50)).
From a practical point of view, RBEDSB is obtained and stored in a look-up table as a function
of particle type and kinetic energy by means of Monte Carlo computations. The MCDS Monte Carlo
code [Semenenko and Stewart, 2004, Wang et al., 2012], which is able to simulate also the dependence
on the oxygen concentration, is typically used in these computations, so that the RMF has been also
used to predict the OER [Stewart et al., 2011] along with the clonogenic data [Frese et al., 2012] and
DSB inductions estimates [Carlson et al., 2008] for ion irradiations.
In panel (b) of figure 12 the RMF prediction of the RBEβ compared with experimental data and the
evaluations of other models, is reported. It is worth noting that the RMF model predicts an increasing
β for increasing LET (see equation (104)). This is in contrast with other models, such as the LEM,
which predict a decreasing β, or the MK model, which, depending on the specific formulation, predicts
both a constant or a decreasing β.
The RMF has been also implemented in a TPS to evaluate the 3D RBE distribution in irradiated
patients [Kamp et al., 2015a]. It is interesting to note that one of the appealing aspects of the RMF
for for TPS studies is that the specific response of the tissue, both healty or tumoral, is explicitly
determined by a single parameter, R. This is a simplification, but allow to study the effect of the
specificity of the tissue response in a direct way, also allowing for a distribution of R values and hence
easily accounting for the variability and the uncertain associated to this clinical parameter.
†Intratrack binary misrepair occurs when an energy deposition along the track forms two or more DSBs that interact
in pairwise mode to form an exchange. Intertrack instead, is a binary misrepair arises from the pairwise interaction of
break ends associated with DSBs that were formed by two separate radiation tracks through a cell.
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5 Summary
In clinical treatment planning, the RBE has to be calculated by radiobiological mathematical
models, which, in spite of all validation efforts, still involve significant sources of uncertainty.
The aim of this review was to present the theoretical aspects of a selection of radiobiological
models that emphasize the link of in-vitro and in-vivo radiobiological outcomes, such as the RBE,
to microdosimetric experimental data. We approached these models through a conceptual sketch of
their assumptions, highlighting the continuity and leaps of their mathematical formulations. For each
model we addressed the limit of applicability and eventual improvements, and the link of their input
parameters to experimental observables.
A particular emphasis to the microdosimetric kinetic (MK) -based models has been given. Starting
from its first seminal formulation by Hawkins in 1994 [Hawkins, 1994] the MK model has represented
an effective approach to link the microdosimetric quantities, which describe the quality of the radiation,
to the radiobiological effects and, at present, it is one of the most widely used model to evaluate the
RBE in both research and clinical applications. The MK modeling approach for RBE evaluations has
gained a particular interest in recent years, with the appearance of different studies aimed to improve
the accuracy of the model and to extend its range of applicability in different biological contexts, such
as the OER prediction and non-target effects.
Although sharing similar theoretical bases, the MK-based models make different assumptions and
approximations in their implementation. Based on these differences, the models considered in this
review (including also the RMF model) make, in particular, different predictions in the dependence of
β on particle LET, and the RBE for cell survival in the overkill regime, for particles with an LET & 150
keV/µm.
Two main aspects of the considered models, where recent efforts have brought interesting insight,
and where further future studies could bring potential improvements, could be identified. One aspect is
the ascertainment of a more accurate link of the theoretical descriptions to specific cellular mechanisms
of DNA damage induction and its evolution, exploiting also information from nanodosimetric data.
Another aspect is to improve the theoretical statistical description of the involved processes, be them
either the stochastic nature of the energy deposition or the stochastic nature of the cell response to
the irradiation.
Future comparisons of model predictions with experimental data are hence needed to fully dis-
criminate among competing mechanisms to be incorporated for the improvement of these model to
evaluate the RBE.
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